At the moment, the company is looking for a professional who will oversee the implantation of the chip and settle issues with US regulators.
Elon Musk's company Neuralink is hiring a specialist to test the neural interface on humans, reports the Chronicle.info with reference to Focus.
Neuralink is looking for a director of clinical trials to lead the implantation of brain implants in volunteers. This officer is also expected to be responsible for interacting with regulatory agencies, such as the Food and Drug Administration (FDA), which reports to the US Department of Health and Human Services. And he will also have to develop standards for operating procedures, control over the conduct of surgical operations, draw up reports and other documents, and interact with inspection services.
The following requirements were put forward for the candidate for the position:
- a thorough understanding of the process of clinical trials;
- knowledge of the laws related to clinical trials;
- knowledge of medical and scientific terminology;
- availability of communication and management skills;
- experience in interaction with the FDA;
- experience in managing research centers;
- experience in working with implantable medical devices of the second or third class;
- experience in operating rooms;
- At least 3 years of experience in US medical device regulation
- Research experience in an Integrated Development Environment (IDE).
«As director of clinical trials, you will work closely with leading doctors and engineers, as well as with the first participants in Neuralink clinical trials», the text of the announcement reads. «You will lead and help build the Neuralink Clinical Trial and Regulatory Development Team».
Neuralink needs to be tested on humans before it can get FDA approval to use the neural interface for medical purposes, because Elon Musk promised that the technology will help patients cope with many neurological diseases, such as memory loss and all sorts of dependencies.
The first step for the company is to get an idea of how the device works in humans and determine a feasibility study. After that, the FDA should review and approve the start of larger trials.